Rafael Laurino
About Rafael Laurino
Rafael Laurino is the Associate Director of Clinical Research Operations Brazil at Bristol-Myers Squibb, based in New York, with over 20 years of experience in the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Rafael Laurino currently holds the position of Associate Director of Clinical Research Operations in Brazil at Bristol-Myers Squibb. Based in New York, New York, United States, he has been with the company for nearly a decade, starting in January 2014. In his role, he oversees the clinical research operations within Brazil, leveraging his extensive experience in the field to ensure smooth and efficient operations.
Previous Experience at Eli Lilly and Company
Rafael Laurino worked at Eli Lilly and Company as a Senior Manager of Clinical Operations in Brazil from 2012 to 2013. During his one-year tenure, he was responsible for managing clinical operations within the country, applying his expertise in clinical research management and regulatory affairs.
Managerial Roles at Roche
Before joining Bristol-Myers Squibb, Rafael Laurino held multiple managerial roles at Roche. He served as a Clinical Research Manager in various capacities from 2008 to 2012. His roles included Regulatory Affairs Manager (2009-2012), Line Manager (2008-2009), and Project Manager (2008). His experience at Roche provided him with a strong foundation in clinical research operations and regulatory affairs.
Early Career at Merck
Rafael Laurino began his career in the pharmaceutical industry at Merck, where he worked as a Clinical Research Administrative Coordinator from 2002 to 2008. His six-year tenure at Merck allowed him to gain valuable experience in clinical research administration, setting the stage for his future roles in the industry.
Educational Background
Rafael Laurino holds a Master of Business Administration degree from Fundação Instituto de Administração - FIA/USP, which he obtained between 2005 and 2007. He also earned a Bachelor's degree from Universidade Cidade de São Paulo, completing his studies there from 1995 to 2000. His educational background has provided him with a strong foundation in business and management, complementing his extensive experience in clinical research operations.